Armstrong AW, Lebwohl M, Warren RB, Sofen H, Imafuku S, Ohtsuki M, Spelman L, Passeron T, Papp KA, Kisa RM, Berger V, Vritzali E, Hoyt K, Colombo MJ, Banerjee S, Strober B, Thaçi D, Blauvelt A. Deucravacitinib in Plaque Psoriasis: 3-Year Safety and Efficacy Results From the Phase 3 POETYK PSO-1 and PSO-2 Trials. J of Skin [Internet]. 2023 Nov. 13 [cited 2024 Jul. 3];7(6):s240. Available from: https://jofskin.org/33014/index.php/skin/article/view/2359